FAM20B

Across TCGA pan-cancer cohorts, FAM20B Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated FAM20B data layer compared with 24 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher FAM20B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FAM20B expression acts as an unfavorable survival marker.

UCEC and CHOL are the cancer types where FAM20B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

FAM20B–UCEC (OS)

Open the UCEC breakdown →